Here’s the latest from Brent Stafford at Regulator Watch

With Canada’s general election now over and the federal Liberals returned to power, the future for nicotine vaping in Canada appears bleak.
Without political intervention, it’s likely nothing could stop Health Canada from implementing its proposed flavour ban, which is certain to decimate the industry.
Joining us today on RegWatch is Clive Bates, tobacco control policy expert and former Director of Action on Smoking and Health (UK). He issues a blistering critique of Health Canada’s cost-benefit analysis, which the regulator is using to justify its dangerous new policy.

Why does Bates call anti-vaping efforts in Canada “absolutely reprehensible and unethical?”

Find out! Only on RegWatch by RegultorWatch.com

Released: Sept 21, 2021
Produced by Brent Stafford

Part of our “Last Stand” coverage

Make RegWatch happen, go to: support.regulatorwatch.com

Well done Amanda Wheeler!

Amanda Wheeler is the president of the American Vapor Manufacturers Association, which she co-founded to represent independent vapor manufacturers navigating the regulatory landscape. She is also the owner of Jvapes E-liquid, established in 2011. Since then, Wheeler has been a strong advocate for vapor products and also serves as the executive director of the Arizona Smoke-Free Business Alliance and the president of the Rocky Mountain Smoke-Free Alliance. She graduated from Lamar University with a Bachelor of Science degree in psychology before pursuing a Master of Arts degree in psychology from Prescott College.

Our friend Amanda gave an excellent keynote speech at the GTNF (Global Tobacco & Nicotine Forum) in London UK expressing the situation we face here in the United States.

INSPIRING | Amanda Wheeler Speaks at GTNF 2021 London from RegulatorWatch.com on Vimeo.

Although Dimitris is still in Greece working on his tan, I host the show with Jay Love from Five Pawns and we have an excellent conversation.

• Talk about some vaping news stories and a call to action for the UK.
• Jay and I discuss the latest actions of the FDA.
• We get his opinions on those actions.
• What steps Five Pawns has been taking to combat those actions.
• Call for a summit of all vape advocacy groups.
• The New Legacy Collection, what it is, and a live tasting!
• + MORE!

Thanks Rod Cochran, AKA The Rodman of VAPE RADIO for listening in on the show and discussing it on your show!
Although I invite you to listen to Rod’s entire show as there’s a lot of good music and points being made, here are some clips specific to the DP Show:

Segment 1
Segment 2
Segment 3

And Rod, FU! I was a nightclub not a wedding DJ! 😉

Here are more links used in the show:

UK CALL TO ACTION – The real threat from the WHO and what UK consumers can and should do about it
truth® Launches Fake Vape Company “Depression Stick!” To Make A Point
Vaping Works If Governments Allow It To

Five Pawns Legacy Collection
The #1 Best Selling Flavor in the Unsalted Line… The Delicious Watermelon Peach (and the other flavors too) @ Dash Vapes (Canada)
The #1 Best Selling Flavor in the Unsalted Line… The Delicious Watermelon Peach (and the other flavors too) @ Rocky Top Vapor (US)

THE VIDEO:

Dimitris is still in Greece, but I’m going to host the show and I’m brining back Jay Love from Five Pawns.

Jay and I will discuss the latest actions of the FDA.
His opinions on those actions.
What steps Five Pawns has been taking to combat those actions.
The New Legacy Collection and a live tasting of the (sorta) new flavors.

PMTAs cost anywhere between $117,000 and $466,000—entirely unaffordable for your average mom-and-pop shop. What’s worse is that manufacturers with different flavored products have to submit these expensive PMTAs multiple times, one for each variant. But according to the FDA, store owners should not fret—at least each application is not “millions of dollars [as] described by some others.” Requiring vape shops to shell out six figures to get approval to sell a product is unreasonable and borderline punitive.

Read the entire article HERE.

Last month, 15 past presidents of the venerable Society for Research on Nicotine and Tobacco (SRNT), the top tobacco research society in the world, co-authored a courageous, groundbreaking article that argues that the media, legislators, and the general public have developed a negative view of e-cigarettes (vaping products) because of the heavy emphasis public health organizations have placed on protecting youth from vaping while ignoring the potentially substantial benefits of e-cigarettes in helping tens of millions of addicted adults quit smoking. The authors lay out thoughtful policy recommendations on how to balance concerns about the risks with the potential benefits.

See the entire article HERE.

Here’s the latest from Brent Stafford at Regulator Watch

In this episode a passionate and pissed off PBusardo joins Brent Stafford, Dimitris Agrafiotis and Amanda Wheeler to discuss the latest FDA death sentence to smokers and vapers alike.

Join RegWatch for a special live episode to unpack the reckless behaviour of the U.S. Food and Drug Administration in its decision to delay authorizations of nicotine vaping products for controversial companies such as Juul. While issuing Marketing Denial Orders for millions of products manufactured and sold by thousands of small businesses operating in the U.S. market.

*Guests: Amanda Wheeler, Exec. Dir., Arizona Smoke Free Business Alliance & President, Rocky Mountain Smoke Free Alliance / Dimitris Agrafiotis, Exec. Dir. Tennessee Smoke Free Association / Phil Busardo, Vape Evangelist
Only on RegWatch by RegulatorWatch.com

Streamed Live: September 10, 2021
Produced by Brent Stafford

This episode is supported by DEMAND VAPE

Make RegWatch happen, go to: support.regulatorwatch.com

Matthew Myers, president of the Campaign for Tobacco Free Kids, which sued the FDA to create the Sept. 9 deadline, applauded that progress but insisted it was not enough.

“While FDA has said it has ruled on 93% of the applications, it hasn’t ruled on the products that have driven the youth e-cigarette epidemic. Every day those products remain on the market, our kids remain in jeopardy,” said Myers. “It is very frustrating that this problem has been allowed to fester for more than a decade. There needs to be a resolution and a resolution quickly.”

Myers added that if the FDA does not decide on the major applications soon, his group will “have no choice but to go back to the court to have the court enforce its order requiring FDA to begin to remove any product not authorized.”

Myers declined to say when the group would go back to court but added that “this can’t be a delay of months, it has to be resolved promptly or else we have to ask a court to intervene.”

Read the entire article HERE.

To me, it looks like we are going to know nothing new, outside of the horrible news we already know, today. To quote a friend, “they are worms”.

Bottom line, NOTHING has been approved, but them cigarettes are still out there though!

They have banned millions of private sector, small business products while delaying the decision on the larger, Big Tobacco owned Juul. Let’s think about that for a second.

Let’s add more job loss, more business loss, more stress, and more death to an already struggling society. But hey, the kids are safe because Mom and Dad can’t control them.

Perhaps the title of this press announcement should have been, “FDA Makes Significant Progress in destroying lives, jobs, and killing people.”

Press announcement from the FDA:

As of today, the agency has taken action on applications for over 6 million ENDS products, including refusing to file (RTF) one company’s applications for approximately 4.5 million products because required contents were missing as well as issuing 132 MDOs for more than 946,000 flavored ENDS products, including flavors such as Apple Crumble, Dr. Cola and Cinnamon Toast Cereal.

We continue to work expeditiously on the remaining applications that were submitted by the court’s Sept. 9, 2020, deadline, many of which are in the final stages of review. For premarket tobacco product applications, our responsibility is to assess whether applicants meet the applicable statutory standard for marketing their new products. As we have said before, the burden is on the applicant to provide evidence to demonstrate that permitting the marketing of their product meets the applicable statutory standard. Our continued review also includes a smaller number of pending applications that are being reviewed under the “substantial equivalence” standard, for cigars, pipes and hookah tobacco and for which we’ve granted marketing orders covering over 350 products.

All new tobacco products on the market without the statutorily required premarket authorization are marketed unlawfully and subject to enforcement action at the FDA’s discretion. The FDA is committed to completing the review of the remaining products as quickly as possible to provide regulatory certainty and will continue to keep the public informed of our progress. In the meantime, products for which no application is pending, including, for example, those with a Marketing Denial Order and those for which no application was submitted, are among our highest enforcement priorities. If such products are not removed from the market, the agency intends to follow its usual enforcement practices in these circumstances and will issue a warning letter before initiating enforcement action (such as civil money penalties, seizure, or injunction) and afford the recipient an opportunity to respond. Since January 2021, we have issued a total of 170 warning letters to firms that collectively have listed more than 17 million ENDS with the FDA and that had not submitted premarket applications for these products. Among those warning letters, and in an effort to take action on products with a likelihood of youth use or initiation, the FDA issued a warning letter in July to a single company that did not submit an application and has more than 15 million products listed with the FDA.

Read the full article HERE.

Our friend Amanda Wheeler appears in this article:

Is the delay just for Juul? I guess we’ll find out later today. I’ll post more as I see it.

The Food and Drug Administration will reportedly seek more time before deciding whether Juul can continue to sell its e-cigarettes in the United States, The Wall Street Journal reported Thursday.

A court mandate created a timeline for the agency to review vaping products, following years of pressure from politicians and public health groups to regulate the segment as strictly as other tobacco products.

The FDA did not immediately respond to CNBC’s request for comment.

See the entire article HERE.